Myo-Inositol Supplementation to Prevent Gestational Diabetes Mellitus

Curr Diab Rep. 2016 Mar;16(3):30. doi: 10.1007/s11892-016-0726-6.

Abstract

Gestational diabetes mellitus (GDM) is a common complication characterized by increased insulin resistance, and by increased risk for adverse pregnancy outcomes affecting both the mother and the fetus. International guidelines describe optimal ways to recognize it, and the recommended treatment of patients affected to reduce adverse outcomes. Improving insulin resistance could reduce incidence of GDM and its complications. Recently, a few trials have been published on the possible prevention of GDM. Inositol has been proposed as a food supplement that might reduce gestational diabetes incidence in high-risk pregnant women.

Keywords: Adverse pregnancy outcome; Gestational diabetes mellitus; Insulin resistance; Myo-inositol; Prevention.

Publication types

  • Review

MeSH terms

  • Animals
  • Diabetes, Gestational / epidemiology
  • Diabetes, Gestational / prevention & control*
  • Dietary Supplements
  • Female
  • Humans
  • Incidence
  • Inositol / therapeutic use*
  • Insulin Resistance
  • Pregnancy
  • Pregnancy Outcome

Substances

  • Inositol